ClinSync Clinical Research Pvt Ltd

What ClinSync Clinical Research Pvt Ltd does

ClinSync Clinical Research Pvt. Ltd. is a Hyderabad-based contract research organization (CRO) established in 2011 that delivers end-to-end clinical research services to pharmaceutical, biotech, biosimilar, and medical device sponsors. Its service portfolio spans Bioavailability/Bioequivalence (BA/BE) studies, Phase II-IV clinical trial operations, bioanalytical method development and sample analysis, clinical data management, pharmacokinetics and biostatistics, pharmacovigilance, medical writing, cold-chain sample management, and (since 2022) FMCG/personal healthcare testing. The company reports more than 390 completed BA/BE studies, 14+ clinical trials, and 100+ method validations across its history, with named customers including Hetero, Aurobindo, Sun Pharma, Alembic, MSN Laboratories, Syngene, Mayo Clinic, and OmniActive.

The company's technical platform is anchored by a 160-bed clinical pharmacology unit (with ICU facilities) at Madeenaguda, Hyderabad, and eight LC-MS/MS systems (API 4000 and API 4500) capable of processing over 30,000 samples per month. Bioanalytical work is supported by a method data bank of 100+ validated assays aligned with FDA, EMEA, NPRA, ANVISA, TGA, and DCGI standards, and clinical data management operates across Medidata Rave, Oracle Clinical RDC, Data Labs, and Inform under 21 CFR Part 11 compliant systems. Pharmacokinetic analysis is performed in Phoenix WinNonlin (v8.3) with statistical analysis in SAS (v9.4), supporting parallel, 2-way crossover, 3-way reference replicate, and 4-way full replicate designs. ClinSync has cleared six USFDA inspections, including a 2023 inspection with zero 483 observations, and holds DSIR recognition in addition to CDSCO, GCC, and NPRA accreditations.

ClinSync operates a fee-for-service, project-based B2B model: revenue is generated through customized study contracts, with pricing determined by study type, complexity, therapeutic area, subject count, and regulatory submission target. Go-to-market is direct enterprise sales via a dedicated business development team, supplemented by participation in industry events and inbound inquiries through [email protected]. The company is privately held, founder/management-owned (per available data, with no disclosed institutional backers or funding rounds), employs 130-148 professionals, and is headquartered in Telangana, India, serving clients across South Asia and select global sponsors.

Name

ClinSync Clinical Research Pvt Ltd

Legal name

ClinSync Clinical Research Pvt. Ltd.

Website

https://clinsync.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

Hyderabad-based ClinSync Clinical Research is a CRO providing BA/BE studies, Phase II-IV clinical trials, bioanalytical services, and clinical data management to pharmaceutical, biotech, biosimilar, and medical device sponsors. Founded 2011, it operates a 160-bed facility staffed by 130+ professionals.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

DMPK / ADME & Bioanalysis (HLAGAFAC), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Clinical research services
• Bioavailability bioequivalence studies
• Bioanalytical services
• Clinical data management
• Contract research organization

Headquarters

HQ city

Hyderabad (Madeenaguda)

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Research Services: Fee-for-service B2B model providing end-to-end clinical research services to pharmaceutical, biotech, biosimilar, and medical device companies. Revenue generated through project-based contracts for BA/BE studies, clinical trials, data management, bioanalytical services, and medical writing.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

ClinSync Clinical Research Pvt Ltd is a Contract Research Organization that delivers outsourced clinical research services to pharmaceutical, biotechnology, biosimilar, and medical device companies. The company conducts Bioavailability/Bioequivalence (BA/BE) studies, Phase II-IV clinical trials, clinical data management, and bioanalytical laboratory analyses on a fee-for-service basis.

Product overview

ClinSync Clinical Research Pvt Ltd is a Contract Research Organization (CRO) established in 2011 in India, providing comprehensive end-to-end services to pharmaceutical, biotech, biosimilar, and medical device industries. The company operates as a unified platform offering BA/BE Studies (390+ completed), Clinical Trial Operations (Phase II-IV), Clinical Data Management, Bioanalytical Services, Clinical Pharmacology, Pharmacokinetics/Biostatistics, Medical Writing, Cold Chain Management, and Personal Healthcare (FMCG) testing services. With a 160-bed clinical facility and 130+ professionals, the company integrates these services to support drug development from early-phase bioequivalence studies through late-phase clinical trials and regulatory submissions.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioavailability/Bioequivalence (BA/BE) Studies Conducted for pharmaceutical and biosimilar manufacturers requiring regulatory bioequivalence data for generic drug submissions and comparative pharmacokinetic studies.
• Clinical Trials (Phase II-IV) Phase II through Phase IV clinical trial design, conduct, and monitoring services for pharmaceutical, biotechnology, and medical device sponsors across multiple therapeutic areas.
• Clinical Data Management Clinical trial database design, data entry, validation, discrepancy management, and database lock services for sponsors running clinical studies.
• Bioanalytical Services Laboratory bioanalytical method development, validation, and sample analysis for pharmacokinetic, bioavailability, and bioequivalence studies, supporting both clinical trials and standalone bioanalytical projects.

Quantifiable outcome

• 390+ BA/BE studies completed
• +6 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators11 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Syngene International: India-based integrated CRO/CDMO serving global pharma and biotech with clinical development, bioanalytical, and data management services. Syngene is a direct peer — also a listed ClinSync customer and competitor for outsourced clinical and bioanalytical work out of India.
• Lambda Therapeutic Research: Indian CRO providing BA/BE, Phase I-IV clinical trials, bioanalytical, and clinical data management services. Lambda is a direct competitor targeting the same generic and biosimilar sponsor base with similar service breadth.
• Cliantha Research: Indian CRO with multi-therapeutic clinical research, bioanalytical, and dermatology/cosmetics testing capabilities. Cliantha competes with ClinSync in both pharma BA/BE and the Personal Healthcare/FMCG testing vertical ClinSync launched in 2022.
• Veeda Clinical Research: Indian CRO headquartered in Ahmedabad offering BA/BE studies, bioanalytical services, and clinical research across therapeutic areas. Veeda is one of ClinSync's closest head-to-head competitors for Indian generic sponsor BA/BE and Phase II-IV outsourcing.
• GVK BIO (Aragen): Hyderabad-headquartered CRO/CDMO offering clinical research, bioanalytical, and discovery services to global pharma. GVK BIO is a directly comparable Indian CRO competing for the same Hyderabad-based sponsor relationships and talent pool.

Broad incumbents

• Parexel International: Global CRO offering Phase I-IV clinical operations, bioanalytical, regulatory, and post-approval services. Parexel is a broad incumbent competitor for multi-country Phase II-IV and bioequivalence work that large pharma sponsors might award instead of a mid-sized Indian CRO.
• IQVIA: Global full-service CRO and clinical technology provider. IQVIA is a broad incumbent that competes for the same Phase II-IV clinical trial and bioanalytical work as ClinSync, with substantially larger global footprint, therapeutic breadth, and scale.
• Labcorp Drug Development (formerly Covance): Global CRO with extensive bioanalytical, central lab, and early-stage clinical capabilities. Labcorp is a broad incumbent that competes for global pharma BA/BE and Phase II-IV work, including USFDA-submission programs that Indian CROs target.
• Charles River Laboratories: Global CRO providing bioanalytical, safety, and clinical research services. Charles River is a broad incumbent competing for the same regulated bioanalytical and Phase II-IV work, particularly for large pharma and biotech sponsors.

Regional players

• Pharmaron: China-headquartered CRO/CDMO offering laboratory, bioanalytical, and clinical research services across geographies. Pharmaron is a regional peer — operates in the same Asia-based outsourcing value proposition that Indian CROs like ClinSync compete within for global sponsor BA/BE and clinical work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Clinsynccro
• LinkedInlinkedin.com/company/clinsync-clinical-research-pvt-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ClinSync Clinical Research Pvt Ltd